Organisms which produce antibiotics must be protected from the lethal effect of their own antibiotics.
The resistance mechanisms in streptomycetes which produce antibiotic inhibitors of protein synthesis have been studied with respect to enzymatic inactivation1-5), resistance of target site6-8) and membrane permeability4,9).
Certain microorganisms producing aminoglycoside antibiotics such as streptomycin and neomycin, do not possess drug-resistant ribosomes; rather, antibiotic-modifying enzymes play the main role of self-protection3-5,10-12). Other aminoglycoside antibiotic-producers which do not possess such enzymes, have ribosomes resistant to the toxic products13,14).
A kanamycin-producing strain, Streptomyces kanamyceticus expresses a kanamycin-acetylating enzyme15). HOTTA et al. 12) , reported that the enzyme played a major role in the resistance mechanism.
However, it was recently demonstrated by others that self-resistance in this strain is attributable to ribosomal resistance acquired with formation of kanamycin16). Thus, various mechanisms of protection can be found in microorganisms which produce the same group of antibiotics. Such observation prompted us to examine self-protection mechanisms in microorganisms which produce other types of antibiotics.
Puromycin, one of the nucleoside antibiotics, inhibits protein synthesis by substituting for aminoacyl t-RNA and serving as an acceptor for the nascent peptide chain of ribosome-bound peptidyl t-RNA17). We and PEREZ-GONZALEZ et al., reported recently that a puromycin-producing organism, Streptomyces alboniger, possessed an enzyme which acetylated the 2"-amino group of O-methyltyrosine moiety of a puromycin molecule in the presence of acetyl coenzyme A18,19) and puromycin 2"-Nacetyltransferase was purified20). We demonstrated that by this means, the producing organism could overcome the toxic effects of the drug20).
Blasticidin S is another nucleoside antibiotic; like puromycin, it inhibits peptide-chain elongation in bacterial and mammalian cells21, 22) In the present study, we show that a strain of blasticidin S-producing actinomycete possesses an activity that inactivates the drug in the presence of acetyl coenzyme A. The substrate specificity of the enzyme and the time course of the production of blasticidin S and blasticidin S-acetylating enzyme were also investigated.
Materials and Methods
Bacterial Strains, Media and Growth Conditions Streptoverticillium sp. JCM 4673 (=Streptomyces morookaensis KCC S-0673) was used as blasticidin S-producing microorganism. This strain is also known to produce 8-azaguanine. Bacillus cereus IFO 3001 was used to assay blasticidin S activity by an agar diffusion method; this bacillus was tolerant up to 100 ug/ml of 8-azaguanine. Streptomyces griseus KSN3-5) and Streptomyces flavotricini subsp. pseudochromogenes V-13-123) were used as strains sensitive to blasticidin S.
Stock cultures of these actinomycetes were maintained on medium containing, per liter, carbon source 10 g, Polypepton 2 g, yeast extract 1 g, meat extract 1 g and agar 20 g, pH 7.0. In the case of the JCM 4673 and KSN strains, fructose was used as carbon source, and glucose was used for growth of the V-13-1 strain. Liquid medium, designated GMP medium, contained per liter, glucose 10 g, NaCl 5 g, Polypepton 4 g, yeast extract 2 g, meat extract 2 g and MgSO4.7H2O 0.25 g, pH 7.0. Bacterial strains were grown in GMP medium at 28°C to a given time in a jar fermentor or a shaking flask.
Blasticidin S Tolerance of the Producing-organism In Vivo One loopful of spore mass was inoculated into 10 ml GMP medium and grown at 28°C for 24 hours. A sample (0.1 ml) of this culture broth was transferred to 10 ml of the same medium containing a given concentration of blasticidin S hydrochloride. Growth was measured after incubation at 28°C for 24 hours.
Preparation of Ribosomes and S-150 Fraction
This was performed according to the methods of SUGIYAMA et al.5), using mycelia grown in GMP medium at 28°C to the late exponential phase of growth.
Cell-free Protein Synthesis Polyuridylate-directed polyphenylalanine synthesis in vitro was carried out according to SUGIYAMA et al.5).
Assay of Blasticidin S-inactivating Activity
The blasticidin S-inactivating enzyme (blasticidin S acetyltransferase) was measured in a reaction mixture (200 µl) consisting of 80 mM Tris-HCl (pH 7.65), 10 mM magnesium acetate, 6 mM 2-mercaptoethanol, 2 mm acetyl coenzyme A, 100 ug blasticidin S hydrochloride and S-150 fraction from Streptoverticillium sp. JCM 4673. The mixture was incubated at 28°C for 1 hour, then heated at 70°C for 10 minutes, followed by centrifugation at 4,700 x g for 10 minutes. A 100-µ1 portion of the supernatant was placed in a well in an agar plate overlayered with spores of B. cereus IFO 3001. Blasticidin S-inactivating activity was measured by the residual antibacterial activity of the drug after acetylation. One unit of enzyme is that activity which acetylates 1 umol of blasticidin S in 1 hour.
Results and Discussion
Initial experiments (data not shown) indicated that Streptoverticillium sp. JCM 4673 was tolerant to blasticidin S hydrochloride to over 100 ug/ml, when cultivated in GMP medium. In contrast, S.
griseus KSN and S. flavotricini subsp. pseudochromogenes V-13-1 were susceptible to 40 ug/ml of the drug under identical growth conditions. This suggested that strain JCM 4673 possessed resistant mechanism(s) to its own antibiotic product.
In the present study, the ribosomes and S-150 fraction from strain JCM 4673 were prepared by 1: Buffer I (10 mM Tris-HCl (pH 7.65), 10 mM magnesium acetate, 6 mm 2-mercaptoethanol and 30 mm NH,Cl), 2: S-150 fraction (480 ug as protein) from JCM 4673 strain, 3: S-150 fraction and acetyl coenzyme A (2 mM), 4: 5-150 fraction and ATP-Na2 (2 mM), 5: buffer I and acetyl coenzyme A, 6: buffer I and ATP-Na2.
The mixture was incubated at 28°C for 1 hour and then at 70°C for 10 minutes. A 100-ul portion of supernatant obtained by a low speed centrifugation was subjected to the antibiotic assay using Bacillus cereus IFO 3001 as a test organism. The reaction mixture (75 µl) was heated at 70°C for 10 minutes and centrifuged to remove precipitate.
A 37.5 ul portion of the resulting supernatant was added to the polyphenylalanine-synthesizing system containing ribosomes from JCM 4673 strain and the S-150 fraction from S. griseus KSN.
Additions are as follows: O; buffer I (37.5 ul), •; S-150 fraction from JCM 4673 strain incubated in the absence of blasticidin S hydrochloride and of acetyl coenzyme A, •; S-150 fraction incubated with blasticidin S and acetyl coenzyme A (2 mM), !; S-150 fraction incubated with blasticidin S. from strain JCM 4673 and the S-150 fraction from S. o riseus KSN. As a result, an efficient polyphenylalanine-synthesizing activity was observed (data not shown), indicating that the ribosomes of strain JCM 4673 were active, and suggesting that the S-150 fraction from the strain may contain some inhibitory factor. This heterogeneous system was used to investigate the effect of blasticidin S on polyphenylalanine synthesis.
As shown in Fig. 1, polyphenylalanine synthesis was inhibited by 0.1 ug/ml blasticidin S, indicating that the ribosomes of the blasticidin S producer were highly susceptible to inhibition by its antibiotic product. This suggests that the strain must have blasticidin S-resistant mechanism(s) other than ribosomal resistance.
We then examined the presence of druginactivating activity in cell extracts of the blasticidin S producer. The activity of blasticidin S disappeared after incubation with acetyl coenzyme The JCM 4673 strain was grown in GMP medium. The specific activity of the enzyme was expressed as unit (see method) per mg protein.
•; Growth, ®; pH, •; amount of blasticidin S (BS) produced in the broth, vertical bars; specific activity of BS acetyltransferase.
One mg of blasticidin S hydrochloride used in this study contains 880 units as acid-free antibiotic.
A and the S-150 fraction from strain JCM 4673 (Fig. 2) . Substitution of ATP for acetyl coenzyme A was ineffective. The inhibitory effect of blasticidin S on the heterogeneous polyphenylalaninesynthesizing system (see above) decreased in the presence of acetyl coenzyme A (Fig. 3) , showing that the blasticidin S-acetylating activity could protect the protein synthesizing machinery in strain JCM 4673.
It is known that several antibiotics are inactivated by acetylation15,18,24-26).
We examined whether the S-150 fraction from strain JCM 4673 could acetylate other antibiotics. Fig. 4 shows that the fraction inactivates strongly streptothricin and puromycin, in the presence of acetyl coenzyme A. However, it should be pointed out that puromycin was completely inactivated by incubation with the S-150 fraction in the absence of added acetyl coenzyme A. Thus, the S-150 fraction appears to have a puromycin-inactivating activity that does not involve acetylation. Weak inactivation of neomycin by the S-150 fraction was observed in the absence of acetyl coenzyme A.
It is known that the production of a streptomycin-inactivating enzyme, streptomycin 6-phosphotransferase, increases with the formation of streptomycin 27) during growth and it was of interest to investigate whether the syntheses of blasticidin S-acetylating enzyme and blasticidin S were linked. There remains the question of whether acetylation is involved in the biosynthesis of blasticidin S in the producing organism. Determination of the site of acetylation, studies on the physico-chemical properties of the enzyme, and of the puromycin-inactivating factor are in progress.
